In summary, ApoE4 aggravates tau pathology and potentiates tau-mediated neurodegeneration [2], which is associated with behavioral alterations, synaptic deregulation and neurodegeneration, and favors AD progression. This evidence concerns the gene MAPT and Alzheimer disease.